Overview
| Gender | Male |
|---|---|
| yongkui.jing@mssm.edu | |
| Education and Training | PhD, Peking Union Medical University and Chinese Academy of Medical Sciences |
| Post-doctoral training, Mount Sinai School of Medicine |
Business Offices
- Address
-
One Gustave L. Levy Place
Box 1178
New York, NY 10029 - Tel
- 212-241-6775
- Fax
- 212-996-5787
Yongkui Jing
ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
Training
| Education and Training | PhD, Peking Union Medical University and Chinese Academy of Medical Sciences |
|---|---|
| Post-doctoral training, Mount Sinai School of Medicine |
Publications
Jing Y, Zhang J, Bleiweiss IB, Waxman S, Zelent A, Mira-Y-Lopez R . Defective expression of cellular retinol binding protein type I and retinoic acid receptors a2, b2, and g2 in human breast cancer cells. FASEB J 1996; 10: 1064-1070.
Jing Y, Waxman S, Mira-Y-Lopez R . The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells. Cancer Res 1997; 57: 1668-1672.
Dai J, Weinberg R, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999; 93: 268-277.
Institutes, Centers, Programs and Laboratories
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Clinical Trials
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
